Chargement en cours...
Introduction of everolimus in kidney transplant recipients at a late posttransplant stage
This minireview focuses on the current knowledge about the introduction of everolimus (EVL), a mammalian target of rapamycin inhibitor, with calcineurin inhibitor (CNI) elimination or minimization in kidney transplant recipients at a late posttransplant stage. Within, we have summarized two major cl...
Enregistré dans:
| Publié dans: | World J Transplant |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6134274/ https://ncbi.nlm.nih.gov/pubmed/30211023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5500/wjt.v8.i5.150 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|